Tectonic Therapeutic, Inc.
Developing biologic therapies that modulate GPCRs for diseases with unmet needs.
TECX | US
Overview
Corporate Details
- ISIN(s):
- US05455M1009
- LEI:
- Country:
- United States of America
- Address:
- 490 ARSENAL WAY, 2472 WATERTOWN
- Website:
- https://tectonictx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs). Utilizing its proprietary GEODe™ technology platform, the company aims to overcome historical challenges in developing biologic medicines for this complex receptor class. Tectonic's pipeline targets diseases with significant unmet medical needs, including Group 2 Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia (HHT). The company's approach is to create highly selective and potent biologics to address conditions with poor or nonexistent therapeutic options, ultimately improving patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tectonic Therapeutic, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tectonic Therapeutic, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tectonic Therapeutic, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
